(Total Views: 646)
Posted On: 11/16/2025 12:24:59 PM
Post# of 158777
Any ICI".
DR. J has never wavered. I will, when he does.
Now Dr. J mentions 12 or so with ICI assets.
I have tossed out many times:
*Friendly LL approach to Chemo/ICI is outstanding. Let them get consolidated on their own.
*ICI form a new Consortium that takes best in class leadership from each "bp", to run the consortium.
Build-out the additional infrastructure & awareness needs.
* All regulatory, city, state, federal, agency dealings like WHO, etc...
* Pay Cytodyn quaterly royalties on solid tumor sales --- that is distributed to Cytodyn shareholders
*Cytodyn continues working with others on remaining indications --- rinse & repeat.
Hub -n-Spoke.
Down the road, if the ICI consortium group wants to buy Cytodyn, $250/$300B (+), is an easy collective amount.
DR. J has never wavered. I will, when he does.
Now Dr. J mentions 12 or so with ICI assets.
I have tossed out many times:
*Friendly LL approach to Chemo/ICI is outstanding. Let them get consolidated on their own.
*ICI form a new Consortium that takes best in class leadership from each "bp", to run the consortium.
Build-out the additional infrastructure & awareness needs.
* All regulatory, city, state, federal, agency dealings like WHO, etc...
* Pay Cytodyn quaterly royalties on solid tumor sales --- that is distributed to Cytodyn shareholders
*Cytodyn continues working with others on remaining indications --- rinse & repeat.
Hub -n-Spoke.
Down the road, if the ICI consortium group wants to buy Cytodyn, $250/$300B (+), is an easy collective amount.
(4)
(0)
